EP1429740A4 - Formulation de noyau comprenant de la troglitazone et un biguanide - Google Patents

Formulation de noyau comprenant de la troglitazone et un biguanide

Info

Publication number
EP1429740A4
EP1429740A4 EP01952549A EP01952549A EP1429740A4 EP 1429740 A4 EP1429740 A4 EP 1429740A4 EP 01952549 A EP01952549 A EP 01952549A EP 01952549 A EP01952549 A EP 01952549A EP 1429740 A4 EP1429740 A4 EP 1429740A4
Authority
EP
European Patent Office
Prior art keywords
troglitazone
biguanide
core formulation
formulation
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01952549A
Other languages
German (de)
English (en)
Other versions
EP1429740A1 (fr
Inventor
Akwete L Adjei
Yaping Zhu
Anthony J Cutie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kos Life Sciences Inc
Original Assignee
Kos Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kos Life Sciences Inc filed Critical Kos Life Sciences Inc
Priority claimed from PCT/US2001/021616 external-priority patent/WO2003005993A1/fr
Publication of EP1429740A1 publication Critical patent/EP1429740A1/fr
Publication of EP1429740A4 publication Critical patent/EP1429740A4/fr
Withdrawn legal-status Critical Current

Links

EP01952549A 2001-07-10 2001-07-10 Formulation de noyau comprenant de la troglitazone et un biguanide Withdrawn EP1429740A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/021616 WO2003005993A1 (fr) 2000-05-01 2001-07-10 Formulation de noyau comprenant de la troglitazone et un biguanide

Publications (2)

Publication Number Publication Date
EP1429740A1 EP1429740A1 (fr) 2004-06-23
EP1429740A4 true EP1429740A4 (fr) 2005-01-26

Family

ID=32067644

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01952549A Withdrawn EP1429740A4 (fr) 2001-07-10 2001-07-10 Formulation de noyau comprenant de la troglitazone et un biguanide

Country Status (5)

Country Link
EP (1) EP1429740A4 (fr)
JP (1) JP2004536842A (fr)
AU (1) AU2001273290B2 (fr)
CA (1) CA2453782A1 (fr)
MX (1) MXPA04000181A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041842A1 (fr) * 1996-05-09 1997-11-13 The Trustees Of The University Of Pennsylvania Particules creuses contenant du calcium et du phosphate du type mineral et destinees a un tissu osseux___________________________
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
WO2000028989A1 (fr) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Composition pharmaceutique a liberation modifiee d'un agent de sensibilisation a l'insuline, et d'un autre agent antidiabetique
DE19860699A1 (de) * 1998-12-30 2000-07-06 Hexal Ag Pharmazeutische Zusammensetzung
WO2000044681A2 (fr) * 1999-02-01 2000-08-03 The Curators Of The University Of Missouri Procede de preparation de coques ou de gels a partir de particules de verre
WO2001035940A2 (fr) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Nouvelle composition et utilisation
WO2001035941A2 (fr) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Nouvelle composition et utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041842A1 (fr) * 1996-05-09 1997-11-13 The Trustees Of The University Of Pennsylvania Particules creuses contenant du calcium et du phosphate du type mineral et destinees a un tissu osseux___________________________
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
WO2000027401A1 (fr) * 1998-11-09 2000-05-18 Warner-Lambert Company Combinaisons contre le diabete contenant une sulfonyluree, un glitazone et un biguanide
WO2000028989A1 (fr) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Composition pharmaceutique a liberation modifiee d'un agent de sensibilisation a l'insuline, et d'un autre agent antidiabetique
DE19860699A1 (de) * 1998-12-30 2000-07-06 Hexal Ag Pharmazeutische Zusammensetzung
WO2000044681A2 (fr) * 1999-02-01 2000-08-03 The Curators Of The University Of Missouri Procede de preparation de coques ou de gels a partir de particules de verre
WO2001035940A2 (fr) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Nouvelle composition et utilisation
WO2001035941A2 (fr) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Nouvelle composition et utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03005993A1 *

Also Published As

Publication number Publication date
MXPA04000181A (es) 2004-11-22
AU2001273290B2 (en) 2004-10-07
EP1429740A1 (fr) 2004-06-23
CA2453782A1 (fr) 2003-01-23
JP2004536842A (ja) 2004-12-09

Similar Documents

Publication Publication Date Title
GB2375299B (en) Playard and a changing table thereof
GB2369270B (en) Cross-charging in a mobile-telecommunication network
IL158437A0 (en) Absorbent article having a multilayer absorbent core
HUP0303955A3 (en) Herbicidal compositions comprising benzoylcyclohexanediones and safeners and a method for their use
GB0316651D0 (en) A universasl software application
EP1455793A4 (fr) Formulation anti-diabete et procede
EP1423399A4 (fr) Chelateurs d'hydroxypyridonate et d'hydroxypyrimidinone
PL370563A1 (en) Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
AU2001227535A8 (en) A core formulation
AU2001227532A1 (en) A core formulation
AU2002337749A1 (en) Pioglitazone hydrochloride
GB2389324B (en) A novel catalytic formulation and its preparation
TW547114U (en) A racket
EP1429747A4 (fr) Preparation de noyau comprenant un hydrochlorure de pioglitazone et un biguanide
EP1511753A4 (fr) Antimicrobiens et leurs utilisations
EP1429732A4 (fr) Formulation de noyau
GB0005122D0 (en) A ballscrew
GB2365032B (en) A sectional structure and parts thereof
EP1429740A4 (fr) Formulation de noyau comprenant de la troglitazone et un biguanide
AU2001273309A1 (en) Core formulation comprising troglitazone and a biguanide
GB0101992D0 (en) Pesticidal formulation
SG104988A1 (en) Leadframe and component with a leadframe
GB0013400D0 (en) A formulation
IL147063A0 (en) Pesticidal formulation
IL153245A0 (en) New formulation comprising a betablocker and optionally a cholesterol-lowering agent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040109

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041210

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 9/50 B

Ipc: 7A 61K 31/4439 B

Ipc: 7A 61K 31/155 B

Ipc: 7A 61K 9/16 A

17Q First examination report despatched

Effective date: 20050323

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050912